sub field
BiotechLongevity
About
Helen McBride, Ph.D. is a Partner at BOLD Capital Partners focused on healthcare and life sciences investing, especially technologies at the intersection of physics and biology. Before BOLD, she held senior scientific and translational roles at Amgen and TORL Biotherapeutics and led healthcare investing for Fund@Caltech. She also holds ecosystem roles including HBA Los Angeles president and A.T. Still University trustee.
Areas of interest
longevitybiotechhealthcarelife sciencesoncologytherapeuticsinflammationmedical devicestranslational medicineexponential technologies